Australian Pharmaceutical Industries Limited

Australian Pharmaceutical Industries Limited (API) currently does not have specific emissions data available for the most recent year, as indicated by the absence of reported figures. However, it is important to note that API is a current subsidiary of Wesfarmers Limited, which may influence its climate commitments and emissions reporting.

As a subsidiary, API's climate initiatives and targets may be aligned with those of Wesfarmers Limited. Wesfarmers has been actively involved in sustainability efforts, including commitments to reduce carbon emissions and improve environmental performance across its operations. While specific reduction targets for API are not detailed, the overarching goals set by Wesfarmers may provide a framework for API's climate strategy.

API has not publicly disclosed any specific science-based targets (SBTi) or reduction initiatives at this time. The absence of a climate pledge or documented reduction targets suggests that API is still in the process of developing its climate action strategy.

In summary, while Australian Pharmaceutical Industries Limited does not currently report specific carbon emissions data or reduction targets, its affiliation with Wesfarmers Limited may play a significant role in shaping its future climate commitments and sustainability initiatives.